LONA
LeonaBio, Inc.
NASDAQ: LONA · HEALTHCARE · BIOTECHNOLOGY
$9.10
+3.76% today
Updated 2026-04-30
Market cap
$78.44M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-24.70
Dividend yield
—
52W range
$2 – $14
Volume
0.1M
LeonaBio, Inc. (LONA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-156.9%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-4878.9%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-6.2%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-8.1%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-27 | $-18.92 | -1393.6% | $9.68 | $9.27 | -4.3% |
| 2025-11-06 | $-1.68 | -1192.3% | $4.19 | $3.85 | -8.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.27 | $-18.92 | -1393.6% | — | — |
| 2025-09-30 | $-0.13 | $-1.68 | -1192.3% | — | — |
| 2025-06-30 | $-0.22 | $-1.78 | -709.1% | — | — |
| 2025-03-31 | $-0.18 | $-0.23 | -27.8% | — | — |
| 2024-12-31 | $-0.38 | $-0.38 | +0.0% | — | — |
| 2024-09-30 | $-0.70 | $-0.75 | -7.1% | — | — |
| 2024-06-30 | $-0.74 | $-0.70 | +5.4% | — | — |
| 2024-03-31 | $-0.69 | $-0.69 | +0.0% | — | — |
| 2023-12-31 | $-0.71 | $-0.71 | +0.0% | — | — |
| 2023-09-30 | $-0.87 | $-0.87 | +0.0% | — | — |
| 2023-06-30 | $-0.78 | $-0.78 | +0.0% | — | — |
| 2023-03-31 | $-0.65 | $-0.19 | +70.8% | — | — |
Frequently asked questions
Has LeonaBio, Inc. beaten earnings estimates?
LeonaBio, Inc. has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -156.9% over the last 4 quarters.
How does LONA stock react to earnings?
LONA stock has moved an average of -6.2% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.